Anne B Chang is an expert in Pulmonology at Queensland Children’s Hospital (Australia). As of October 2026, ScienceLeadR ranks Anne B Chang in the top 1% of experts worldwide for Cough, Bronchiectasis and Tracheobronchomalacia. Anne B Chang has authored 697 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 2,357 (community average: 125). How the SLR is computed.

LeadR Profile

Anne B Chang Queensland Children’s Hospital Australia
2 357 ScienceLeadR Reputation 2357
Network Map

Pulmonology

Subspecialties: Pediatrics - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026

Source: PubMed

Menzies School of Health Research

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 697

Citations

Citations: 33 039 1st author: 126 Last author: 256 Unique author: 13


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Phase III AIRTIVITY study design: verducatib (BI 1291583) in people with bronchiectasis.
PMID 42820152 — safety, bronchiectasis
ERJ Open Res20262
Barriers and Facilitators to Timely Detection and Optimal Management of Chronic Wet Cough in Aboriginal Children Across Australia From the Perspective of Health Care Providers: A Qualitative Study.
PMID 42815950 — respiratory tract infections, solutions, child health, health personnel, cough, child
Med J Aust20260
Advancing equity: six-year respiratory outcomes in young Indigenous children following early respiratory disease detection.
PMID 42586381 — lung, longitudinal studies, prevalence, vital capacity, bronchiectasis, child
Respir Med20260
Web-Based Physiotherapy Resources for Bronchiectasis: Evaluation of Content, Quality, and Implementation Evidence.
PMID 42717469 — exercise, internet, health education, bronchiectasis, physical therapy modalities
Physiother Res Int20260
Change is coming? The concept of FEV 1 change score in predicting asthma exacerbations.
PMID 42532730 — research design, respiratory tract diseases, therapeutics, accidental falls, asthma
Paediatr Respir Rev20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 4
N/A 1
Phase 4 1

By status:

Completed 4
Active not recruiting 1
Recruiting 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The AIRTIVITY Study A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892 — safety, tablets, bronchiectasis
Phase 3Recruiting2025

LeadR Networks

Main global connection map